Teva Pharmaceutical Industries Ltd..
Israeli pharmaceutical company
- Reports this week
- 4
- Active events
- 2
- Connections
- 146
What's happening
Active this week
Earlier this month
-
Teva Pharmaceutical Industries discussed company strategy at an event hosted by Morgan Stanley.Some support2 reports
-
Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.Well supported6 reports
-
Teva Pharmaceutical announces it is embarking on debt recycling through bond issuance, concurrent with rating agencies raising its debt rating.Some support1 report
-
Drone attacks targeted facilities of Teva Pharmaceutical Industries in Ukraine, where the company operates.Some support1 report
-
A partnership between Direct Relief and Teva Pharmaceutical Industries Ltd. has been established to facilitate the supply of donated inhalers.Some support1 report
-
Chris Fox, President of Teva USA, discussed drug pricing priorities for American patients.Some support2 reports
-
Teva Pharmaceutical Industries Ltd. submitted an NDA for ecopipam to the FDA.Well supported9 reports
-
The market capitalization of Teva Pharmaceutical Industries was overtaken by another entity on the Tel Aviv Stock Exchange.Some support1 report
One to three months ago
-
Teva is challenging Aurinia's patents regarding LUPKYNIS, while Aurinia defends against generic applications from Sandoz.Some support2 reports
-
Teva's acquired product is currently undergoing review by the FDA.Some support1 report
-
Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.Some support4 reports
-
Teva and Apotex are entering the Tolvaptan market, while Lupin reports sales growth in North America and India.Some support1 report
-
The FDA completed the first-cycle review of an Abbreviated New Drug Application (ANDA) involving NRx Pharmaceuticals and Teva.Some support1 report
-
Teva Pharmaceutical Industries launched a biosimilar product in Europe.Some support2 reports
-
Companies, including Saipem and Fresenius Medical Care, are divesting from the energy sector and channeling capital into family-owned holdings.Some support1 report
-
Deckers Brands reported strong earnings driven by Ugg and Hoka, while Stefano Caroti was named CEO of the company.Some support2 reports
-
Health Canada approved OPUVIZ for market access in Canada, alongside a license agreement for the drug.Some support1 report
-
Teva Pharmaceutical Industries is competing with major players Bayer, Biogen, and Novartis in the aflibercept biosimilar market.Some support1 report1 development inside
-
Teva Pharmaceutical Industries Ltd. gained exclusive global rights to commercialize a biosimilar.Some support2 reports
-
Teva partners with Sanofi for Duvakitug development.Well supported5 reports
-
Richard Francis has been appointed as the new CEO of Teva Pharmaceutical Industries Ltd.Some support2 reports
Gone quiet
No new reports in 90+ days-
Tower Semiconductor Ltd. became Israel's most valuable company, surpassing Bank Leumi's market cap. Check Point succeeded Teva as most valuable, while Teva's stock suffered due to the Actavis acquisition.Some support1 report
-
Teva sandals are sold on Amazon, and Jessica Alba was seen wearing them during a trip to Rome.Some support1 report
-
Clarivate and Teva Pharmaceutical Industries Ltd. announced their support for antimicrobial stewardship programs globally.Some support1 report1 development inside
-
Clarivate and Teva Pharmaceutical Industries Ltd. supported antimicrobial stewardship programs, including one in Kenya.Some support2 reports
-
Amazon hosted Prime Day sales event on June 22, 2026, featuring brands including Teva.Some support1 report
-
Application for olanzapine is under FDA review.Some support1 report
-
Multiple financial institutions, including Migdal, Harel, Norges Bank, Ardsley, and Menora Mivtachim, made various investment moves regarding Teva stock.Some support1 report
-
Teva's asset received FDA Orphan Drug and Fast Track designations after announcing an acquisition from Tel Aviv.Some support3 reports
-
Michael Denzer's career path includes pivotal roles at Bristol Myers Squibb, Amgen, and Teva, with his most recent company being Civica.Some support1 report
-
Tina Katcheves gained professional experience from both Teva Pharmaceuticals and Bristol Myers Squibb on August 27, 2025, involving Acadia Pharmaceuticals.Some support2 reports
-
Philippe Martin was named Viatris' chief R&D officer, while Novartis and Teva are noted for drug approvals and generic production.Well supported4 reports1 development inside
-
Fosun Pharmaceutical and Teva announced a partnership to co-develop novel cancer immunotherapy, alongside reports that tariffs benefit AI stocks.Speculative1 report
-
Teva plans to launch Austedo in European markets and partnered with Sanofi for duvakitug.Some support1 report1 development inside
-
The FDA approved the launch of generic Saxenda on September 6, 2025.Some support3 reports
-
Teva was recognized in the World's Most Sustainable Companies list, which involved contributions from Statista.Speculative1 report
-
Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.Some support2 reports
-
Aucedo is an FDA-approved treatment.Some support1 report
-
Amgen and Teva launched Stelara biosimilars in the US.Some support1 report
-
J&J faces patent challenges and competitive pressure from biosimilars launched by Amgen and Teva, compounded by new price setting requirements under the Inflation Reduction Act.Some support2 reports1 development inside
-
FDA approved label expansion for Teva's Ajovy, following joint CGRP-targeting drug development with Novartis.Some support2 reports
-
Corcept Therapeutics faces patent litigation with Teva, a situation that Joon Lee has questioned.Some support1 report
-
Teva obtained FDA approval for a generic drug, challenging Novo Nordisk's market share in the GLP-1RA space.Some support2 reports
-
Deckers Outdoor collaborated with Sean Wotherspoon to launch a new collection for outdoor explorers.Some support1 report
-
Teva designed a new line of footwear, updated for performance, to encourage connection with Earth's wild spaces.Some support2 reports
-
PureTech Ventures launched Celea, a new respiratory disease treatment, with Sven Dethlefs appointed to lead its program advancement.Some support2 reports1 development inside
-
Catalyst Pharmaceuticals, a US biopharma company, is licensed by SERB and previously settled litigation with Teva Pharmaceuticals.Some support2 reports
-
Teva Pharmaceutical Industries, an Israeli company, had its study results presented at a congress held in Helsinki.Speculative1 report
-
Teva Pharmaceutical Industries issued a press release from Tel Aviv.Some support3 reports
-
Johnson & Johnson, Eli Lilly, Sandoz, and Teva are key market players, with a news release issued from Austin, TX.Some support2 reports2 developments inside
-
Teva Pharmaceutical Industries, an Israeli company based in Tel Aviv, is scheduled to present at a conference in London.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Teva Pharmaceutical Industries Ltd. this week
News at the entities that move Teva Pharmaceutical Industries Ltd. most-
Donald Trump TransactionalThe Trump administration utilized the Department of Health & Human Services for an AI tool.Moves Teva Pharmaceutical Industries Ltd.
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Teva Pharmaceutical Industries Ltd.
-
Mylan OperationalZymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Moves Teva Pharmaceutical Industries Ltd.
-
Novartis OperationalNovartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Moves Teva Pharmaceutical Industries Ltd.
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Teva Pharmaceutical Industries Ltd.
-
Leerink partners Mentioned togetherAnalyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Moves Teva Pharmaceutical Industries Ltd.
Connections
The 40 strongest of 146, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Chris Fox Structural
Chris Fox holds executive roles within Teva, including global marketing business head and President of Teva USA.
-
Richard Francis Structural
Richard Francis serves as the Chief Executive Officer of Teva Pharmaceutical Industries Ltd.
-
Donald Trump Transactional
Trump's administration negotiated and announced specific drug pricing and cost reduction agreements with Teva Pharmaceuticals.
-
Eric Hughes Structural
Eric Hughes holds executive positions, including CMO and Executive VP, at Teva Pharmaceutical Industries Ltd.
-
Richard Francis Structural
Richard Francis serves as the CEO and President of Teva Pharmaceutical Industries Ltd.
-
FDA Structural
The FDA exercises formal regulatory authority over Teva's pharmaceutical products, governing approvals, designations, and market access.
-
Deckers Outdoor Corporation Structural
Deckers incorporates Teva as a proprietary brand name and product line, leveraging its presence for brand recognition and investor enthusiasm.
-
Novartis Operational
Novartis and Teva actively compete in the global pharmaceutical market, particularly in generics and biosimilars.
Show all 40 connections
-
Mylan Operational
Teva and Mylan are direct competitors in the generic drug market and have been implicated in anti-competitive practices regarding generic release timelines.
-
BAYER Operational
The two companies are actively competing in the aflibercept biosimilar market.
-
Menora Mivtachim Holdings Ltd Transactional
Menora Mivtachim successfully established a stake/position in Teva Pharmaceutical Industries.
-
Actavis Structural
Actavis was acquired by Teva, establishing a structural dependency where Actavis' fate was tied to the larger entity.
-
Biogen Operational
Biogen and Teva are direct competitors in the aflibercept biosimilar market.
-
Competition Authority Operational
The Competition Authority is currently investigating Teva regarding generic competition practices.
-
Clarivate Operational
Clarivate and Teva actively collaborate on global antimicrobial stewardship programs.
-
Astellas Pharma Operational
The companies are active competitors, evidenced by their shared involvement in drug pricing agreements.
-
MarketBeat Mentioned together
MarketBeat aggregates and reports financial data and broker ratings for Teva Pharmaceutical Industries Ltd.
-
Migdal Insurance & Financial Holdings Ltd. Transactional
Migdal increased its investment holdings in Teva stock.
-
Leerink partners Mentioned together
Leerink Partners provides financial coverage and ratings on Teva Pharmaceutical Industries Ltd. stock.
-
Shanghai Operational
Teva and Shanghai maintain an operational partnership focused on R&D and licensed supply rights.
-
Direct Relief Operational
Direct Relief and Teva Pharmaceutical Industries Ltd. partner to facilitate the supply of donated inhalers.
-
Norges Bank Structural
Norges Bank acquired a new investment position in Teva Pharmaceutical Industries Ltd.
-
New York Shared context
Teva Pharmaceutical Industries Ltd. is listed on the Wall Street market, which is located in New York.
-
Check Point Operational
Check Point and Teva were historically compared in terms of market valuation, with Check Point succeeding Teva as the most valuable company.
-
UBS Mentioned together
UBS provides market rating updates on Teva's stock.
-
New York Stock Exchange Structural
Teva is establishing its market presence by listing its shares on the New York Stock Exchange.
-
Reuters Mentioned together
Reuters reports on the stock performance of Teva Pharmaceutical Industries Ltd.
-
Amazon Transactional
Amazon functions as a sales platform where Teva's products are listed and featured in sales events.
-
Europe Shared context
Teva operates and targets markets within Europe for its pharmaceutical products.
-
Apotex Operational
Apotex and Teva are noted as large generic competitors in the market.
-
Cape Town Operational
A firm in Cape Town is involved in distributing Teva's pharmaceutical products across the African continent.
-
Francisco García Paramés Transactional
The relationship is characterized by a divestment from the energy sector.
-
Nasdaq Shared context
Teva operates as a publicly listed company on the Nasdaq stock exchange.
-
Kenya Operational
The operational focus includes shared stewardship programs regarding responsible antibiotic use.
-
Tel Aviv Stock Exchange Shared context
Teva Pharmaceutical Industries Ltd. is listed and trades on the Tel Aviv Stock Exchange, sharing the same market context.
-
Alcon Shared context
Both companies operate within the pharmaceutical market context and are subject to shared drug pricing agreements.
-
Truist Financial Mentioned together
Truist Financial raised its price target on Teva stock, representing market coverage and influence.
-
Tel Aviv Shared context
Teva Pharmaceutical Industries Ltd. is headquartered and operates within the city of Tel Aviv.
-
Morgan Stanley Operational
Teva discussed its corporate strategy during an event hosted by Morgan Stanley.
-
World Health Organization Shared context
Both entities operate within Ukraine and are reported to be targeted.
History
Events by the month they beganSeptember 2026
6 events- Teva Pharmaceutical Industries Ltd. is being investigated by the Competition Authority regarding generic competition practices.
- Leerink partners issued an 'outperform' rating on Teva stock, while an insider sold shares of the company.
- Teva Pharmaceutical Industries discussed company strategy at an event hosted by Morgan Stanley.
- Teva Pharmaceutical announces it is embarking on debt recycling through bond issuance, concurrent with rating agencies raising its debt rating.
- Drone attacks targeted facilities of Teva Pharmaceutical Industries in Ukraine, where the company operates.
- A partnership between Direct Relief and Teva Pharmaceutical Industries Ltd. has been established to facilitate the supply of donated inhalers.
August 2026
7 events- Chris Fox, President of Teva USA, discussed drug pricing priorities for American patients.
- The market capitalization of Teva Pharmaceutical Industries was overtaken by another entity on the Tel Aviv Stock Exchange.
- Teva is challenging Aurinia's patents regarding LUPKYNIS, while Aurinia defends against generic applications from Sandoz.
- Teva's acquired product is currently undergoing review by the FDA.
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Teva and Apotex are entering the Tolvaptan market, while Lupin reports sales growth in North America and India.
- The FDA completed the first-cycle review of an Abbreviated New Drug Application (ANDA) involving NRx Pharmaceuticals and Teva.
July 2026
7 events- Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
- Teva Pharmaceutical Industries launched a biosimilar product in Europe.
- Companies, including Saipem and Fresenius Medical Care, are divesting from the energy sector and channeling capital into family-owned holdings.
- Deckers Brands reported strong earnings driven by Ugg and Hoka, while Stefano Caroti was named CEO of the company.
- Health Canada approved OPUVIZ for market access in Canada, alongside a license agreement for the drug.
- Teva Pharmaceutical Industries Ltd. gained exclusive global rights to commercialize a biosimilar.
- Richard Francis has been appointed as the new CEO of Teva Pharmaceutical Industries Ltd.
Show 1 earlier month
June 2026
33 events- Teva Pharmaceutical Industries Ltd. submitted an NDA for ecopipam to the FDA.
- Teva Pharmaceutical Industries is competing with major players Bayer, Biogen, and Novartis in the aflibercept biosimilar market.
- Teva partners with Sanofi for Duvakitug development.
- Tower Semiconductor Ltd. became Israel's most valuable company, surpassing Bank Leumi's market cap. Check Point succeeded Teva as most valuable, while Teva's stock suffered due to the Actavis acquisition.
- Teva sandals are sold on Amazon, and Jessica Alba was seen wearing them during a trip to Rome.
- Clarivate and Teva Pharmaceutical Industries Ltd. announced their support for antimicrobial stewardship programs globally.
- Clarivate and Teva Pharmaceutical Industries Ltd. supported antimicrobial stewardship programs, including one in Kenya.
- Amazon hosted Prime Day sales event on June 22, 2026, featuring brands including Teva.
- Application for olanzapine is under FDA review.
- Multiple financial institutions, including Migdal, Harel, Norges Bank, Ardsley, and Menora Mivtachim, made various investment moves regarding Teva stock.
- Teva's asset received FDA Orphan Drug and Fast Track designations after announcing an acquisition from Tel Aviv.
- Michael Denzer's career path includes pivotal roles at Bristol Myers Squibb, Amgen, and Teva, with his most recent company being Civica.
- Tina Katcheves gained professional experience from both Teva Pharmaceuticals and Bristol Myers Squibb on August 27, 2025, involving Acadia Pharmaceuticals.
- Philippe Martin was named Viatris' chief R&D officer, while Novartis and Teva are noted for drug approvals and generic production.
- Fosun Pharmaceutical and Teva announced a partnership to co-develop novel cancer immunotherapy, alongside reports that tariffs benefit AI stocks.
- Teva plans to launch Austedo in European markets and partnered with Sanofi for duvakitug.
- The FDA approved the launch of generic Saxenda on September 6, 2025.
- Teva was recognized in the World's Most Sustainable Companies list, which involved contributions from Statista.
- Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.
- Aucedo is an FDA-approved treatment.
- Amgen and Teva launched Stelara biosimilars in the US.
- J&J faces patent challenges and competitive pressure from biosimilars launched by Amgen and Teva, compounded by new price setting requirements under the Inflation Reduction Act.
- FDA approved label expansion for Teva's Ajovy, following joint CGRP-targeting drug development with Novartis.
- Corcept Therapeutics faces patent litigation with Teva, a situation that Joon Lee has questioned.
- Teva obtained FDA approval for a generic drug, challenging Novo Nordisk's market share in the GLP-1RA space.
- Deckers Outdoor collaborated with Sean Wotherspoon to launch a new collection for outdoor explorers.
- Teva designed a new line of footwear, updated for performance, to encourage connection with Earth's wild spaces.
- PureTech Ventures launched Celea, a new respiratory disease treatment, with Sven Dethlefs appointed to lead its program advancement.
- Catalyst Pharmaceuticals, a US biopharma company, is licensed by SERB and previously settled litigation with Teva Pharmaceuticals.
- Teva Pharmaceutical Industries, an Israeli company, had its study results presented at a congress held in Helsinki.
- Teva Pharmaceutical Industries issued a press release from Tel Aviv.
- Johnson & Johnson, Eli Lilly, Sandoz, and Teva are key market players, with a news release issued from Austin, TX.
- Teva Pharmaceutical Industries, an Israeli company based in Tel Aviv, is scheduled to present at a conference in London.